BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 15647254)

  • 1. Regulation of amphetamine-stimulated dopamine efflux by protein kinase C beta.
    Johnson LA; Guptaroy B; Lund D; Shamban S; Gnegy ME
    J Biol Chem; 2005 Mar; 280(12):10914-9. PubMed ID: 15647254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
    Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB
    Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein kinase C-mediated functional regulation of dopamine transporter is not achieved by direct phosphorylation of the dopamine transporter protein.
    Chang MY; Lee SH; Kim JH; Lee KH; Kim YS; Son H; Lee YS
    J Neurochem; 2001 May; 77(3):754-61. PubMed ID: 11331404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PKC phosphorylates residues in the N-terminal of the DA transporter to regulate amphetamine-induced DA efflux.
    Wang Q; Bubula N; Brown J; Wang Y; Kondev V; Vezina P
    Neurosci Lett; 2016 May; 622():78-82. PubMed ID: 27113203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of amphetamine transport vs. dopamine reverse transport on particulate PKC activity in striatal synaptoneurosomes.
    Giambalvo CT
    Synapse; 2003 Aug; 49(2):125-33. PubMed ID: 12740868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase Cbeta is a critical regulator of dopamine transporter trafficking and regulates the behavioral response to amphetamine in mice.
    Chen R; Furman CA; Zhang M; Kim MN; Gereau RW; Leitges M; Gnegy ME
    J Pharmacol Exp Ther; 2009 Mar; 328(3):912-20. PubMed ID: 19098163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein kinase C inhibitors block amphetamine-mediated dopamine release in rat striatal slices.
    Kantor L; Gnegy ME
    J Pharmacol Exp Ther; 1998 Feb; 284(2):592-8. PubMed ID: 9454802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine and norepinephrine transporter-dependent c-Fos production in vitro: relevance to neuroadaptation.
    Yatin SM; Miller GM; Madras BK
    J Neurosci Methods; 2005 Apr; 143(1):69-78. PubMed ID: 15763138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sigma(2)-receptor regulation of dopamine transporter via activation of protein kinase C.
    Derbez AE; Mody RM; Werling LL
    J Pharmacol Exp Ther; 2002 Apr; 301(1):306-14. PubMed ID: 11907188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine transporter-dependent induction of C-Fos in HEK cells.
    Yatin SM; Miller GM; Norton C; Madras BK
    Synapse; 2002 Jul; 45(1):52-65. PubMed ID: 12112414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular Ca2+ regulates amphetamine-induced dopamine efflux and currents mediated by the human dopamine transporter.
    Gnegy ME; Khoshbouei H; Berg KA; Javitch JA; Clarke WP; Zhang M; Galli A
    Mol Pharmacol; 2004 Jul; 66(1):137-43. PubMed ID: 15213305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PI 3-kinase regulation of dopamine uptake.
    Carvelli L; MorĂ³n JA; Kahlig KM; Ferrer JV; Sen N; Lechleiter JD; Leeb-Lundberg LM; Merrill G; Lafer EM; Ballou LM; Shippenberg TS; Javitch JA; Lin RZ; Galli A
    J Neurochem; 2002 May; 81(4):859-69. PubMed ID: 12065645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotinic receptor-mediated regulation of the dopamine transporter in rat prefrontocortical slices following chronic in vivo administration of nicotine.
    Drew AE; Werling LL
    Schizophr Res; 2003 Dec; 65(1):47-55. PubMed ID: 14623374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine transporter antagonists block phorbol ester-induced dopamine release and dopamine transporter phosphorylation in striatal synaptosomes.
    Cowell RM; Kantor L; Hewlett GH; Frey KA; Gnegy ME
    Eur J Pharmacol; 2000 Feb; 389(1):59-65. PubMed ID: 10686296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct and Systemic Administration of a CNS-Permeant Tamoxifen Analog Reduces Amphetamine-Induced Dopamine Release and Reinforcing Effects.
    Carpenter C; Zestos AG; Altshuler R; Sorenson RJ; Guptaroy B; Showalter HD; Kennedy RT; Jutkiewicz E; Gnegy ME
    Neuropsychopharmacology; 2017 Sep; 42(10):1940-1949. PubMed ID: 28492278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphetamine regulation of dopamine transport. Combined measurements of transporter currents and transporter imaging support the endocytosis of an active carrier.
    Kahlig KM; Javitch JA; Galli A
    J Biol Chem; 2004 Mar; 279(10):8966-75. PubMed ID: 14699142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter.
    Pifl C; Drobny H; Reither H; Hornykiewicz O; Singer EA
    Mol Pharmacol; 1995 Feb; 47(2):368-73. PubMed ID: 7870046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amphetamine-induced decreases in dopamine transporter surface expression are protein kinase C-independent.
    Boudanova E; Navaroli DM; Melikian HE
    Neuropharmacology; 2008 Mar; 54(3):605-12. PubMed ID: 18164041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential targeting of the dopamine transporter to recycling or degradative pathways during amphetamine- or PKC-regulated endocytosis in dopamine neurons.
    Hong WC; Amara SG
    FASEB J; 2013 Aug; 27(8):2995-3007. PubMed ID: 23612789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brief, repeated exposure to substrates down-regulates dopamine transporter function in Xenopus oocytes in vitro and rat dorsal striatum in vivo.
    Gulley JM; Doolen S; Zahniser NR
    J Neurochem; 2002 Oct; 83(2):400-11. PubMed ID: 12423250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.